Nantes University Hospital
Nantes, France
Location status: Recruiting
NCT Number: NCT01248767
This research aims to provide a better understanding of the factors associated with the evolution of behavioral addictions, and compliance with care. The investigators thus aim to follow patients with several types of behavioral addictions, based on addictive, sociodemographic, clinical and endophenotypical characteristics, as well as their care adhesion.
Interested in participating?
Request Info15 year and older
All sexes
Observational
Nantes, France
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 years
Understand what determines the evolution of behavioral addictions and compliance with care. Study the outcome of patients with behavioral addictions, both in terms of the evolution of of the addictive pathology and associated clinical and endophenotypic characteristics, as well as adherence to care.
Contact information is provided by the study sponsor or research team.
Nantes University Hospital
Other
A Prospective Clinical Study of a Cohort of Pathological Patients Seeking Treatment for a Behavioral Addiction in the University Hospital of Nantes
Acronym: EVALADD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07421765
Addictive Behavior, Behavior
Nantes, France
View Trial DetailsNCT05540288
Behavior, Behavior, Addictive
Besançon, France
View Trial DetailsNCT07661823
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Richmond, Virginia, United States
View Trial DetailsNCT01052831
Basal Ganglia Diseases, Behavior
Philadelphia, Pennsylvania, United States
View Trial Details